Infectious complications in SLE after immunosuppressive therapies.
about
Amplification of autoimmune disease by infectionVaccination of Adult Patients with Systemic Lupus Erythematosus in PortugalPsychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice.Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults.Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.Infection in systemic lupus erythematosus: friend or foe?Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study.Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort.Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.Case report-right iliac fossa mass in an HIV-positive woman. Cryptococcal meningitis.Challenges in bringing the bench to bedside in drug development for SLE.Review article: BK virus in systemic lupus erythematosusEmergence of targeted immune therapies for systemic lupus.Pneumococcal sepsis in patients with systemic lupus erythematosus.Infections and SLE.High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus.Pulse Therapy in Pemphigus: Ready ReckonerSpecial regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier.Vaccine-preventable infections in Systemic Lupus Erythematosus.Vaccination in patients with chronic rheumatic or autoimmune diseases.Intraabdominal cryptococcal lymphadenitis in a patient with systemic lupus erythematosus.The case for Zostavax vaccination in systemic lupus erythematosus.Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.Systemic lupus erythematosus: a genetic review for advanced practice nurses.Invasive fungal infection in Chinese patients with systemic lupus erythematosus.Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Distinguishing infections vs flares in patients with systemic lupus erythematosus.Elimination of autoreactive B cells in humanized SCID mouse model of SLE.Colonic perforation in a patient with systemic lupus erythematosus accompanied by cytomegalovirus infection: A case report.Opportunistic cytomegalovirus infection causing colonic perforation in a patient with systemic lupus erythematosus.Serious Infection Rates among Children with Systemic Lupus Erythematosus Enrolled in Medicaid.Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus.The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients.Systemic lupus erythematosus and infections: a retrospective study in Saudis.Invasive pulmonary fungal infections in patients with connective tissue disease: a retrospective study from northern China.Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.
P2860
Q24804390-153CB1DD-FF05-4300-A805-83E3B070A011Q26749096-0E1DB6EC-7E21-4A74-8611-26E0599ADC54Q30480323-A094871C-B84E-4CC6-87F5-14F63340DC10Q33446433-DDB29AB4-1526-4B5B-8B93-57FC6B959FFBQ33586280-34AE8AAA-0A34-415A-B4BB-60BAFCEA4D9BQ33623765-1782255F-46A6-48B1-B9C3-B8C91CD0CCBCQ33690722-30F40D28-1FE0-4966-A058-ECCAB3ACBAA5Q33696879-A0C94BCF-B2B4-4809-9AFA-A600B8908AB0Q34394435-418C1827-0C21-437B-A3FF-F00909B0CE64Q35141927-EF5BF338-5995-4F14-A184-EC2F9E7009A7Q35792458-6C5576C7-4EC4-4679-94F9-A159F013458CQ35938465-D21DF198-4EB5-4C2A-9EF7-AE3119A07F57Q35968394-F536C85A-00B9-4F5C-97D2-F23CDB415D04Q35986282-F3B0D9D4-7104-415B-9C75-463F70AFF6D7Q36066014-858129CA-3526-4F62-B891-D6C6FFA65627Q36334477-55E1F72A-4457-4C54-BF5B-B52B5CD56971Q36350798-330FE4CB-5454-4AF2-A7EE-9F2E32452254Q36896784-7515148F-3305-4A68-8414-8D12D9950131Q36947253-7324FA8C-6BF4-42E0-B327-060AC4347741Q37043710-FC327222-3EAD-4AD6-B96F-8202110686B9Q37135056-8837E12E-E128-48CE-AC6A-8159347F87EDQ37141193-350E9918-BA9F-42D6-9405-E29E4AC6FA06Q37425794-72883B85-059F-4AB6-9466-8D10E96249C9Q37634514-EA91C58A-AC24-4B3D-ACD7-248BBA371E9AQ37690737-A1E098F7-009C-4537-9641-EFD58463F70DQ37965222-D1E43F0D-7074-46E4-A6F3-7A2436CEC79AQ38000006-DF36A940-D4AB-42D3-8912-60AF80A94F24Q38153509-703EDF59-0BA8-4444-9C66-5B54C3A327BAQ38182646-1130A314-0DD8-4B65-AD46-5320DF4D7F22Q38981689-6345563E-8D33-45E2-83C0-8868E0690D85Q39492463-EDEE5F28-2179-42F5-9E41-2863C984B422Q40109239-81763860-2942-4DAC-B221-1DA7ED29F088Q40308296-91F9671A-C0B2-43E6-8C9B-66C36B0CA4DEQ40325720-D658FEA6-51F6-45ED-BD65-3C77730CBAD8Q40374986-49F0F395-C2C9-4BA8-B307-0865A3F49AC9Q40385337-628D1247-CF40-40CA-AEA4-B286F8479B89Q40440734-660EA7E5-6CED-4F32-AA8D-551069AB249EQ40523292-EE2134D8-49AB-485E-BBEB-6B2B9F374D1AQ40752218-F3A5F0B6-E36C-4F6D-B28B-92183A6DBBC2Q41029099-DF65882F-B58E-4D35-818F-CEBD27ABDAB4
P2860
Infectious complications in SLE after immunosuppressive therapies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Infectious complications in SLE after immunosuppressive therapies.
@ast
Infectious complications in SLE after immunosuppressive therapies.
@en
type
label
Infectious complications in SLE after immunosuppressive therapies.
@ast
Infectious complications in SLE after immunosuppressive therapies.
@en
prefLabel
Infectious complications in SLE after immunosuppressive therapies.
@ast
Infectious complications in SLE after immunosuppressive therapies.
@en
P1476
Infectious complications in SLE after immunosuppressive therapies.
@en
P2093
Insoo Kang
Sung Hwan Park
P304
P356
10.1097/00002281-200309000-00002
P577
2003-09-01T00:00:00Z